Actionable news
All posts from Actionable news
Actionable news in NOK: NOKIA CORPORATION,

Wednesday Morning’s Market Insights: Juno Therapeutics Inc (JUNO), GW Pharmaceuticals PLC- ADR (GWPH), Nokia Corp (ADR) (NOK)

Juno Therapeutics Inc (NASDAQ:JUNO) is up 20% in early trading after the FDA removed the clinical hold on its Phase 2 clinical trial of JCAR015, a immunotherapy pipeline drug targeted to patients with specific types of leukemia. Last week, the FDA placed a clinical hold on the trial following the deaths of 2 patients, likely caused by the combination with fludarabine, a chemotherapy drug. The news caused shares to fall 32%. Juno responded by filing documents to the FDA with revised protocol and patient requirements. The company is now resuming enrollment in the study without fludarabine.

According to TipRanks, out of the 7 analysts who have rated the company in the past 3 months, 4 gave a Buy rating while 3 remain neutral. The average 12-month price...